AbstractBackgroundThe TRILUMINATE Pivotal trial is a prospective, randomized, controlled study of patients with severe tricuspid regurgitation (TR). Venous congestion due to TR may lead to end-orga…
Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland Pumpinheart Ltd, Galway, Ireland Tissue Engineering Research Group, RCSI University of Medicine…
Gauthier and colleagues evaluated concomitant ibrutinib and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in a study of patients with chronic ly
Nephrology Times is proud to feature Freely Filtered and Channel Your Enthusiasm, leading health care podcasts covering the latest research in the nephrology space.
While CAR-T cell therapy has emerged as a transformative salvage option for around 40% of patients, long-term data on allo-HSCT remain sparse, research shows.
The U.S. Surgeon General’s office released a new advisory on the link between alcohol consumption and increased risk for cancer. The advisory reports alcohol use…
And a bit of hope for 2025
Ferring has advanced three clinical trials assessing nadofaragene as a monotherapy and combination therapy for NMIBC.
AbstractBackgroundArtificial intelligence–enhanced electrocardiogram (AI-ECG) analysis shows promise to predict mortality in adults with acquired cardiovascular diseases. However, its application t…
Juan Jose Rodriguez-Sevilla, MD, PhD, summarizes current clinical knowledge about inflammation within MDS pathobiology.
Background:Poor fitness in middle age is a risk factor for heart failure, particularly heart failure with a preserved ejection fraction. The development of heart failure…
